Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 11 October 2001
Science 9 November 2001:
Vol. 294. no. 5545, pp. 1343 - 1346
DOI: 10.1126/science.1065817
Prev | Table of Contents | Next

Reports

A Phosphatase Associated with Metastasis of Colorectal Cancer

Saurabh Saha, Alberto Bardelli,* Phillip Buckhaults, Victor E. Velculescu, Carlo Rago, Brad St. Croix, Katharine E. Romans, Michael A. Choti, Christoph Lengauer, Kenneth W. Kinzler,dagger Bert Vogelsteindagger

To gain insights into the molecular basis for metastasis, we compared the global gene expression profile of metastatic colorectal cancer with that of primary cancers, benign colorectal tumors, and normal colorectal epithelium. Among the genes identified, the PRL-3 protein tyrosine phosphatase gene was of particular interest. It was expressed at high levels in each of 18 cancer metastases studied but at lower levels in nonmetastatic tumors and normal colorectal epithelium. In 3 of 12 metastases examined, multiple copies of the PRL-3 gene were found within a small amplicon located at chromosome 8q24.3. These data suggest that the PRL-3 gene is important for colorectal cancer metastasis and provide a new therapeutic target for these intractable lesions.

Howard Hughes Medical Institute, The Oncology Center, Department of Surgery, and Program in Cellular and Molecular Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
*   On leave from the University of Torino, Institute for Cancer Research, 10060 Candiolo, Torino, Italy.

dagger    To whom correspondence should be addressed. E-mail: kinzlke{at}jhmi.edu (K.W.K.); vogelbe{at}welch.jhu.edu (B.V.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells.
L. Wang, Y. Shen, R. Song, Y. Sun, J. Xu, and Q. Xu (2009)
Mol. Pharmacol. 76, 1238-1245
   Abstract »    Full Text »    PDF »
PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma.
K. GUZINSKA-USTYMOWICZ, A. PRYCZYNICZ, and A. KEMONA (2009)
Anticancer Res 29, 3913-3916
   Abstract »    Full Text »    PDF »
Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer.
I. Bernard-Pierrot, N. Gruel, N. Stransky, A. Vincent-Salomon, F. Reyal, V. Raynal, C. Vallot, G. Pierron, F. Radvanyi, and O. Delattre (2008)
Cancer Res. 68, 7165-7175
   Abstract »    Full Text »    PDF »
Translational Control of C-terminal Src Kinase (Csk) Expression by PRL3 Phosphatase.
F. Liang, Y. Luo, Y. Dong, C. D. Walls, J. Liang, H.-Y. Jiang, J. R. Sanford, R. C. Wek, and Z.-Y. Zhang (2008)
J. Biol. Chem. 283, 10339-10346
   Abstract »    Full Text »    PDF »
Chromosomal Breakpoints in Primary Colon Cancer Cluster at Sites of Structural Variants in the Genome.
J. Camps, M. Grade, Q. T. Nguyen, P. Hormann, S. Becker, A. B. Hummon, V. Rodriguez, S. Chandrasekharappa, Y. Chen, M. J. Difilippantonio, et al. (2008)
Cancer Res. 68, 1284-1295
   Abstract »    Full Text »    PDF »
A Selective Phosphatase of Regenerating Liver Phosphatase Inhibitor Suppresses Tumor Cell Anchorage-Independent Growth by a Novel Mechanism Involving p130Cas Cleavage.
S. Daouti, W.-h. Li, H. Qian, K.-S. Huang, J. Holmgren, W. Levin, L. Reik, D. L. McGady, P. Gillespie, A. Perrotta, et al. (2008)
Cancer Res. 68, 1162-1169
   Abstract »    Full Text »    PDF »
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
U.-M. Fagerli, R. U. Holt, T. Holien, T. K. Vaatsveen, F. Zhan, K. W. Egeberg, B. Barlogie, A. Waage, H. Aarset, H. Y. Dai, et al. (2008)
Blood 111, 806-815
   Abstract »    Full Text »    PDF »
Phosphatase Activity, Trimerization, and the C-terminal Polybasic Region Are All Required for PRL1-mediated Cell Growth and Migration.
J.-P. Sun, Y. Luo, X. Yu, W.-Q. Wang, B. Zhou, F. Liang, and Z.-Y. Zhang (2007)
J. Biol. Chem. 282, 29043-29051
   Abstract »    Full Text »    PDF »
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
D. G. Mollevi, T. Serrano, M. M. Ginesta, J. Valls, J. Torras, M. Navarro, E. Ramos, J. R. Germa, E. Jaurrieta, V. Moreno, et al. (2007)
Carcinogenesis 28, 1241-1246
   Abstract »    Full Text »    PDF »
PRL-3 Down-regulates PTEN Expression and Signals through PI3K to Promote Epithelial-Mesenchymal Transition.
H. Wang, S. Y. Quah, J. M. Dong, E. Manser, J. P. Tang, and Q. Zeng (2007)
Cancer Res. 67, 2922-2926
   Abstract »    Full Text »    PDF »
PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation.
F. Liang, J. Liang, W.-Q. Wang, J.-P. Sun, E. Udho, and Z.-Y. Zhang (2007)
J. Biol. Chem. 282, 5413-5419
   Abstract »    Full Text »    PDF »
Protein Kinase CK2{alpha} as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia.
J. S. Kim, J. I. Eom, J.-W. Cheong, A. J. Choi, J. K. Lee, W. I. Yang, and Y. H. Min (2007)
Clin. Cancer Res. 13, 1019-1028
   Abstract »    Full Text »    PDF »
PRL-1 Tyrosine Phosphatase Regulates c-Src Levels, Adherence, and Invasion in Human Lung Cancer Cells.
H. Achiwa and J. S. Lazo (2007)
Cancer Res. 67, 643-650
   Abstract »    Full Text »    PDF »
Clonal and Parallel Evolution of Primary Lung Cancers and Their Metastases Revealed by Molecular Dissection of Cancer Cells.
K. Takahashi, T. Kohno, S. Matsumoto, Y. Nakanishi, Y. Arai, S. Yamamoto, T. Fujiwara, N. Tanaka, and J. Yokota (2007)
Clin. Cancer Res. 13, 111-120
   Abstract »    Full Text »    PDF »
PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo.
K. Guo, J. Li, H. Wang, M. Osato, J. P. Tang, S. Y. Quah, B. Q. Gan, and Q. Zeng (2006)
Cancer Res. 66, 9625-9635
   Abstract »    Full Text »    PDF »
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
L Wang, L Peng, B Dong, L Kong, L Meng, L Yan, Y Xie, and C Shou (2006)
Ann. Onc. 17, 1517-1522
   Abstract »    Full Text »    PDF »
Imaging and Oncologic Drug Development.
W. S. El-Deiry, C. C. Sigman, and G. J. Kelloff (2006)
J. Clin. Oncol. 24, 3261-3273
   Abstract »    Full Text »    PDF »
The Selenium Metabolite Methylselenol Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells.
H. Zeng, M. Briske-Anderson, J. P. Idso, and C. D. Hunt (2006)
J. Nutr. 136, 1528-1532
   Abstract »    Full Text »    PDF »
Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers..
J. M. Cerutti, F. R.M. Latini, C. Nakabashi, R. Delcelo, V. P. Andrade, M. J. Amadei, R. M.B. Maciel, F. C. Hojaij, D. Hollis, J. Shoemaker, et al. (2006)
Clin. Cancer Res. 12, 3311-3318
   Abstract »    Full Text »    PDF »
PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility..
J. J. Fiordalisi, P. J. Keller, and A. D. Cox (2006)
Cancer Res. 66, 3153-3161
   Abstract »    Full Text »    PDF »
Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function..
C. Rouleau, A. Roy, T. St. Martin, M. R. Dufault, P. Boutin, D. Liu, M. Zhang, K. Puorro-Radzwill, L. Rulli, D. Reczek, et al. (2006)
Mol. Cancer Ther. 5, 219-229
   Abstract »    Full Text »    PDF »
PRL phosphatases as potential molecular targets in cancer.
B. J. Stephens, H. Han, V. Gokhale, and D. D. Von Hoff (2005)
Mol. Cancer Ther. 4, 1653-1661
   Abstract »    Full Text »    PDF »
PRL-3 Phosphatase Is Implicated in Ovarian Cancer Growth.
F. Polato, A. Codegoni, R. Fruscio, P. Perego, C. Mangioni, S. Saha, A. Bardelli, and M. Broggini (2005)
Clin. Cancer Res. 11, 6835-6839
   Abstract »    Full Text »    PDF »
Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases.
J. Li, K. Guo, V. W. C. Koh, J. P. Tang, B. Q. Gan, H. Shi, H. X. Li, and Q. Zeng (2005)
Clin. Cancer Res. 11, 2195-2204
   Abstract »    Full Text »    PDF »
DRO1, a Gene Down-regulated by Oncogenes, Mediates Growth Inhibition in Colon and Pancreatic Cancer Cells.
G. T. Bommer, C. Jager, E.-M. Durr, S. Baehs, S. T. Eichhorst, T. Brabletz, G. Hu, T. Frohlich, G. Arnold, D. C. Kress, et al. (2005)
J. Biol. Chem. 280, 7962-7975
   Abstract »    Full Text »    PDF »
5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms.
R. Schneider-Stock, M. Diab-Assef, A. Rohrbeck, C. Foltzer-Jourdainne, C. Boltze, R. Hartig, P. Schonfeld, A. Roessner, and H. Gali-Muhtasib (2005)
J. Pharmacol. Exp. Ther. 312, 525-536
   Abstract »    Full Text »    PDF »
Prolonged Butyrate Treatment Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells.
H. Zeng and M. Briske-Anderson (2005)
J. Nutr. 135, 291-295
   Abstract »    Full Text »    PDF »
From the Cover: 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-{beta}-induced suppressor of human gastrointestinal cancers.
M. Yan, R. M. Rerko, P. Platzer, D. Dawson, J. Willis, M. Tong, E. Lawrence, J. Lutterbaugh, S. Lu, J. K. V. Willson, et al. (2004)
PNAS 101, 17468-17473
   Abstract »    Full Text »    PDF »
Alterations in Vascular Gene Expression in Invasive Breast Carcinoma.
B. S. Parker, P. Argani, B. P. Cook, H. Liangfeng, S. D. Chartrand, M. Zhang, S. Saha, A. Bardelli, Y. Jiang, T. B. St. Martin, et al. (2004)
Cancer Res. 64, 7857-7866
   Abstract »    Full Text »    PDF »
High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer: A Predictive Molecular Marker of Metachronous Liver and Lung Metastases.
H. Kato, S. Semba, U. A. Miskad, Y. Seo, M. Kasuga, and H. Yokozaki (2004)
Clin. Cancer Res. 10, 7318-7328
   Abstract »    Full Text »    PDF »
Genome-Wide Profiling of Papillary Thyroid Cancer Identifies MUC1 as an Independent Prognostic Marker.
V. B. Wreesmann, E. M. Sieczka, N. D. Socci, M. Hezel, T. J. Belbin, G. Childs, S. G. Patel, K. N. Patel, G. Tallini, M. Prystowsky, et al. (2004)
Cancer Res. 64, 3780-3789
   Abstract »    Full Text »    PDF »
Phosphatase of Regenerating Liver-3 Promotes Motility and Metastasis of Mouse Melanoma Cells.
X. Wu, H. Zeng, X. Zhang, Y. Zhao, H. Sha, X. Ge, M. Zhang, X. Gao, and Q. Xu (2004)
Am. J. Pathol. 164, 2039-2054
   Abstract »    Full Text »    PDF »
Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers.
Z. Wang, D. Shen, D. W. Parsons, A. Bardelli, J. Sager, S. Szabo, J. Ptak, N. Silliman, B. A. Peters, M. S. van der Heijden, et al. (2004)
Science 304, 1164-1166
   Abstract »    Full Text »    PDF »
Structural Insights into Molecular Function of the Metastasis-associated Phosphatase PRL-3.
G. Kozlov, J. Cheng, E. Ziomek, D. Banville, K. Gehring, and I. Ekiel (2004)
J. Biol. Chem. 279, 11882-11889
   Abstract »    Full Text »    PDF »
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.
T.-L. Wang, L. A. Diaz Jr., K. Romans, A. Bardelli, S. Saha, G. Galizia, M. Choti, R. Donehower, G. Parmigiani, I.-M. Shih, et al. (2004)
PNAS 101, 3089-3094
   Abstract »    Full Text »    PDF »
PRL-3 Expression in Metastatic Cancers.
A. Bardelli, S. Saha, J. A. Sager, K. E. Romans, B. Xin, S. D. Markowitz, C. Lengauer, V. E. Velculescu, K. W. Kinzler, and B. Vogelstein (2003)
Clin. Cancer Res. 9, 5607-5615
   Abstract »    Full Text »    PDF »
Exposure of Human Primary Colon Carcinoma Cells to Anti-Fas Interactions Influences the Emergence of Pre-existing Fas-Resistant Metastatic Subpopulations.
K. Liu, E. McDuffie, and S. I. Abrams (2003)
J. Immunol. 171, 4164-4174
   Abstract »    Full Text »    PDF »
Identification of Novel Genes Preferentially Expressed in the Retina Using a Custom Human Retina cDNA Microarray.
I. Chowers, T. L. Gunatilaka, R. H. Farkas, J. Qian, A. S. Hackam, E. Duh, M. Kageyama, C. Wang, A. Vora, P. A. Campochiaro, et al. (2003)
Invest. Ophthalmol. Vis. Sci. 44, 3732-3741
   Abstract »    Full Text »    PDF »
PRL-3 and PRL-1 Promote Cell Migration, Invasion, and Metastasis.
Q. Zeng, J.-M. Dong, K. Guo, J. Li, H.-X. Tan, V. Koh, C. J. Pallen, E. Manser, and W. Hong (2003)
Cancer Res. 63, 2716-2722
   Abstract »    Full Text »    PDF »
Consequences of Nonadaptive Alterations in Cancer.
A. Kamb (2003)
Mol. Biol. Cell 14, 2201-2205
   Full Text »    PDF »
Gain of Chromosome 8q23-24 Is a Predictive Marker for Lymph Node Positivity in Colorectal Cancer.
B. M. Ghadimi, M. Grade, T. Liersch, C. Langer, A. Siemer, L. Fuzesi, and H. Becker (2003)
Clin. Cancer Res. 9, 1808-1814
   Abstract »    Full Text »    PDF »
Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
I. Hedenfalk, M. Ringner, A. Ben-Dor, Z. Yakhini, Y. Chen, G. Chebil, R. Ach, N. Loman, H. Olsson, P. Meltzer, et al. (2003)
PNAS 100, 2532-2537
   Abstract »    Full Text »    PDF »
Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference.
N. S. Williams, R. B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel, and C. Becerra (2003)
Clin. Cancer Res. 9, 931-946
   Abstract »    Full Text »    PDF »
Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array-CGH.
J. M. Lage, J. H. Leamon, T. Pejovic, S. Hamann, M. Lacey, D. Dillon, R. Segraves, B. Vossbrinck, A. Gonzalez, D. Pinkel, et al. (2003)
Genome Res. 13, 294-307
   Abstract »    Full Text »    PDF »
Novel Somatic Mutations of the MET Oncogene in Human Carcinoma Metastases Activating Cell Motility and Invasion.
A. Lorenzato, M. Olivero, S. Patane, E. Rosso, A. Oliaro, P. M. Comoglio, and M. F. Di Renzo (2002)
Cancer Res. 62, 7025-7030
   Abstract »    Full Text »    PDF »
A Quantitative Analysis of Rate-limiting Steps in the Metastatic Cascade Using Human-specific Real-Time Polymerase Chain Reaction.
A. Zijlstra, R. Mellor, G. Panzarella, R. T. Aimes, J. D. Hooper, N. D. Marchenko, and J. P. Quigley (2002)
Cancer Res. 62, 7083-7092
   Abstract »    Full Text »    PDF »
Pentamidine Is an Inhibitor of PRL Phosphatases with Anticancer Activity.
M. K. Pathak, D. Dhawan, D. J. Lindner, E. C. Borden, C. Farver, and T. Yi (2002)
Mol. Cancer Ther. 1, 1255-1264
   Abstract »    Full Text »    PDF »
The Tyrosine Phosphatase PRL-1 Localizes to the Endoplasmic Reticulum and the Mitotic Spindle and Is Required for Normal Mitosis.
J. Wang, C. E. Kirby, and R. Herbst (2002)
J. Biol. Chem. 277, 46659-46668
   Abstract »    Full Text »    PDF »
AACR Special Meeting in Cancer Research: Colon Cancer--Genetics to Prevention.
C. N. Johnstone, L. M. Chang, and M. Ernst (2002)
Cancer Res. 62, 6779-6783
   Full Text »    PDF »
Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines.
T. Weinschenk, C. Gouttefangeas, M. Schirle, F. Obermayr, S. Walter, O. Schoor, R. Kurek, W. Loeser, K.-H. Bichler, D. Wernet, et al. (2002)
Cancer Res. 62, 5818-5827
   Abstract »    Full Text »    PDF »
An anatomy of normal and malignant gene expression.
K. Boon, E. C. Osorio, S. F. Greenhut, C. F. Schaefer, J. Shoemaker, K. Polyak, P. J. Morin, K. H. Buetow, R. L. Strausberg, S. J. de Souza, et al. (2002)
PNAS 99, 11287-11292
   Abstract »    Full Text »    PDF »
Novel Therapy for Liver Cancer: Direct Intraarterial Injection of a Potent Inhibitor of ATP Production.
J.-F. H. Geschwind, Y. H. Ko, M. S. Torbenson, C. Magee, and P. L. Pedersen (2002)
Cancer Res. 62, 3909-3913
   Abstract »    Full Text »    PDF »
Gastric Cancers Overexpress DARPP-32 and a Novel Isoform, t-DARPP.
W.'e. El-Rifai, M. F. Smith Jr., G. Li, A. Beckler, V. S. Carl, E. Montgomery, S. Knuutila, C. A. Moskaluk, H. F. Frierson Jr., and S. M. Powell (2002)
Cancer Res. 62, 4061-4064
   Abstract »    Full Text »    PDF »
Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents.
G. W. Birrell, J. A. Brown, H. I. Wu, G. Giaever, A. M. Chu, R. W. Davis, and J. M. Brown (2002)
PNAS 99, 8778-8783
   Abstract »    Full Text »    PDF »
.
(2002)
Vet. Pathol. 39, 292
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)